Clinical trial
A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso
NCT00452088 · African Malaria Network Trust, Other · Unknown status
Key facts
| NCT number | NCT00452088 |
|---|---|
| Title | A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso |
| Official title | Randomized, Controlled, Dose Escalation Phase Ib Trial of MSP 3 LSP Adjuvanted in Aluminium Hydroxide Versus Hepatitis Bin 12 to 24 Month Old Children in Burkina Faso. |
| Acronym | MSP3LSP |
| Lead sponsor | African Malaria Network Trust, Other |
| Collaborators | London School of Hygiene and Tropical Medicine |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | MSP 3 Long Synthetic Peptide, Hepatitis B vaccine, Hepatitis B control vaccince |
| Enrollment | 45 |
| Start date | Apr 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Mar 26, 2007 |
| Last update posted | May 7, 2008 |
| Countries | Burkina Faso |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: